
GSK近日公布,其在研反义寡核苷酸药物bepirovirsen治疗慢性乙型肝炎的两项关键3期临床试验取得突破性阳性结果。数据同步发表于《新英格兰医学杂志》,并在欧洲肝脏研究学会年会上公布,有望改写全球慢乙肝治疗格局。
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Free AI-powered recaps of 天方烨谈 and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.